Prof. Anne Wing-Mui Lee

Clinical Oncologist
The University of Hong Kong, Hong Kong

Professor Anne Lee is the Chief of Service for the Centre of Clinical Oncology at The University of Hong Kong-Shenzhen Hospital in China and the Chair of Specialty for Oncology at Gleneagles Hong Kong Hospital. She is also the Honorary Consultant, Departments of Clinical Oncology at Queen Mary Hospital and Pamela Youde Nethersole Eastern Hospital in Hong Kong. Currently, she is the Vice President of Hong Kong College of Radiologists and the Vice Chairman of Hong Kong Anti-Cancer Society. She also serves in many international academic organizations, including being the Coordinator of the Global Advisory Group and a member of TNM Expert Advisory Panel on Head and Neck Cancers for the Union for International Cancer Control; Vice-Chairman of the National Cancer Staging Committee of China.

Prof. Lee has received many awards and honors, including the Sir Patrick Manson Gold Medal by The University of Hong Kong in 2008; Gilbert H. Fletcher Distinguished Professor Lecturer by The University of Texas, M.D. Anderson Cancer Center, United States, in 2009; Honorary Membership by the European Society for Radiotherapy & Oncology in 2012; Honorary Membership by the Radiological Society of North America in 2013; and Wharton Lecturer by Princess Margaret Cancer Centre, Canada, in 2015.

Prof. Lee’s main research contributions focus on nasopharyngeal cancer. Currently, she serves as an Associate Editor for Oral Oncology, a member of the Board of Editors for Journal of Clinical Oncology, Radiotherapy; Oncology, and Clinical Oncology.


My Journey in Research on Nasopharyngeal Cancer

My journey started under the inspiration of my first mentor Prof. John Ho, one of the greatest pioneers on nasopharyngeal cancer (NPC). He taught us that cancer treatment must be evidence-based; and if data is lacking, we should initiate our own research. For NPC, with its uniquely skewed distribution, Asian centers play a key role in the needed research.

I started my research to address questions most frequently encountered in clinical management. As a medical doctor working in a busy government service departments, without research grants and supports by other university scientists, the challenges and limitations are obviously formidable.  With perseverance and concerted team efforts, we managed to come up with useful messages covering the whole spectrum of clinical issues from staging & prognostication, radiotherapy techniques and dose fractionation, chemotherapy sequence and regimen, late toxicities, and management of recurrence.

In more recent years, I also attempt to conduct studies that can have impact on global health policy and international standards. Furthermore, with taking up of academic post, I began to participate more in translational studies in collaboration with scientists and virologists.

This talk is aimed at sharing of my experience, particularly with young researchers. Summary of my research on NPC and the lessons that I have learnt along my journey will be presented.